- Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
- Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
- Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
- Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
- Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
- Quanterix to Present at Cowen’s 44th Annual Health Care Conference
- Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call
More ▼
Key statistics
As of last trade, Quanterix Corp (QTRX:NMQ) traded at 15.76, 38.36% above the 52 week low of 11.39 set on Apr 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.73 |
---|---|
High | 16.33 |
Low | 15.67 |
Bid | 15.75 |
Offer | 15.76 |
Previous close | 15.79 |
Average volume | 428.75k |
---|---|
Shares outstanding | 38.06m |
Free float | 34.74m |
P/E (TTM) | -- |
Market cap | 601.02m USD |
EPS (TTM) | -0.8587 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 18:51 BST.
More ▼